Dublin, Ireland – Chromaphor Analysen-Technik to distribute VenaFlux™ Platform and products.

Cellix Ltd announced a distribution agreement with the German based company, Chromaphor Analysen-Tecknik. Chromaphor will handle sales and service agreements for Cellix products in Germany.

“We selected Chromaphor as our distribution partner in Germany because of their proven sales methods,” explained Vivienne Williams, CEO, Cellix. “Chromaphor has exceptional insights into the cell biology markets and a customer base that is an ideal fit for our products.”

Chromaphor is a leading provider of innovative scientific products to researchers in the life science markets. With a focus on understanding customer applications and requirements, Chromaphor invests heavily in providing first-class technical and service support as well as an efficient sales process.

“We are very excited about bringing Cellix’s unique products to our customers in Germany,” stated Hugo Ostermann, Managing Director of Chromaphor. “The VenaFlux™ Platform and accessories provides exciting new tools for our customers and fits very well with our existing product portfolio”.

About Chromaphor

Chromaphor was founded in 1995 as a distributor and systems integrator for innovative scientific instruments, reagents and accessories for the life sciences market. The focus is now on microscopy imaging and chromatography and represents international players within Europe.

About Cellix Ltd

Cellix Ltd. (cellixtld.com) is a privately held instrumentation and cell-based assay company developing technologies that accurately mimic in vivo human blood vessels under physiological flow for cell-based screening in drug discovery. The Company is headquartered in Dublin, Ireland, and maintains offices in New York City.